SPONSOR
Blueprint Medicines Corporation
Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Blueprint Medicines Corporation is a clinical research sponsor with 1 registered studies on ClinicalTrials.gov, of which 1 are actively recruiting participants. Research covers conditions including Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Blueprint Medicines Corporation
How many clinical trials has Blueprint Medicines Corporation sponsored?
ClinicalMetric currently tracks 1 clinical trials sponsored by Blueprint Medicines Corporation, of which 1 are actively recruiting participants. These trials cover conditions including Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Blueprint Medicines Corporation research focus on?
Blueprint Medicines Corporation clinical trials span Indolent Systemic Mastocytosis, Smoldering Systemic Mastocytosis. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Blueprint Medicines Corporation clinical trial?
To participate in a Blueprint Medicines Corporation trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Blueprint Medicines Corporation trials with current recruitment status updated daily.
Clinical Trials by Blueprint Medicines Corporation
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology